Vertex Pharmaceuticals
VRTX
VRTX
1,119 hedge funds and large institutions have $68.6B invested in Vertex Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 113 funds opening new positions, 432 increasing their positions, 404 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,119
Holders Change
+18
Holders Change %
+1.63%
% of All Funds
19.35%
Holding in Top 10
39
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+21.88%
% of All Funds
0.67%
New
113
Increased
432
Reduced
404
Closed
80
Calls
$445M
Puts
$436M
Net Calls
+$8.76M
Net Calls Change
+$21.6M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$864M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$395M |
| 3 |
Amundi
Paris,
France
|
+$270M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$213M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$202M |
Top Sellers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$194M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$151M |
| 3 |
Holocene Advisors
New York
|
-$141M |
| 4 |
JPMorgan Chase & Co
New York
|
-$109M |
| 5 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$103M |
